Skip to Main Content

Get Opthea Updates

Company
Science
Clinical Trials
Investors
News
Contact

Opthea Reports Fiscal Year 2022 Financial Results and Corporate Highlights

by Samuel Nee | Aug 30, 2022 | Announcements

COMPANY

Mission & Vision
Company Overview
Management Team
Board of Directors
Medical Advisory Board
COAST and ShORe Steering Committee

SCIENCE

Opportunity
Technology / Mechanism
Pipeline Overview
Scientific Presentations

CLINICAL TRIALS

wet AMD: Phase 3
wet AMD: Phase 2b
wet AMD: Phase 1/2a
DME: Phase 1b/2a
Publications
Expanded Access Policy

INVESTORS

General Information
Press Releases
In the Media
Events & Presentations
SEC Filings
Financial Reports

News
Contact Us

Privacy Policy | Terms of Use | Cookie Notice | © 2023 Opthea Limited. All rights reserved.

Privacy Policy | Terms of Use | Cookie Policy

© 2023 Opthea Limited. All rights reserved.